Alpha Tau Medical
- Country
- 🇮🇱Israel
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 121
- Market Cap
- -
- Website
- http://www.alphatau.com
- Introduction
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
- Conditions
- Metastatic Pancreatic CancerPancreatic AdenocarcinomaPancreatic CancerUnresectable Pancreatic Cancer
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 15
- Registration Number
- NCT05657743
- Locations
- 🇮🇱
Wolfson Medical Center, H̱olon, Israel
🇮🇱Hadassah Ein Kerem, Jerusalem, Israel
Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer
- Conditions
- Lung CancerRecurrent Lung Cancer
- First Posted Date
- 2022-12-01
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT05632913
- Locations
- 🇮🇱
Hadassah University Hospital, Jerusalem, Israel
A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma
- Conditions
- Recurrent Squamous Cell Carcinoma
- Interventions
- Device: DaRT seeds
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 86
- Registration Number
- NCT05323253
- Locations
- 🇺🇸
Day Star Skin and Cancer Center, DeLand, Florida, United States
🇺🇸Integrity Research Clinical Associates, Delray Beach, Florida, United States
🇺🇸Palm Beach Dermatology Group, Delray Beach, Florida, United States
A Retrospective Analysis to Evaluate Long Term Outcomes of SCC Patients Previously Treated With Alpha DaRT
- Conditions
- DaRT Treated PatientsSquamous Cell Carcinoma
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 33
- Registration Number
- NCT05125354
- Locations
- 🇮🇹
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola, Italy
🇮🇱Davidof Cancer Institution at the Rabin Medical Center Israel, Petah tikva, Israel
Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC
- Conditions
- Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
- First Posted Date
- 2021-10-04
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 79
- Registration Number
- NCT05065346
- Locations
- 🇮🇱
Sharett institute, Hadassah University Hospital - Ein-Kerem, Jerusalem, Israel
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
- Conditions
- Head and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma
- Interventions
- Device: Diffusing Alpha Radiation Emitters Therapy (DaRT)
- First Posted Date
- 2021-09-16
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 48
- Registration Number
- NCT05047094
- Locations
- 🇮🇱
Sheba Medical Center, Ramat Gan, Israel
🇮🇱Tel-Aviv Medical Center, Tel Aviv, Israel
🇮🇱Sharett institute, Hadassah University Hospital - Ein-Kerem, Jerusalem, Israel
Neoadjuvant Interstitial Brachytherapy Using Diffusing Alpha Emitters Radiation Therapy in Men With Prostate Cancer
- Conditions
- Prostate Adenocarcinoma
- First Posted Date
- 2020-09-10
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT04543903
- Locations
- 🇮🇱
Tel Aviv Medical Center, Tel Aviv, Israel
🇮🇱Carmel Medical Center, Haifa, Israel
🇮🇱RAMBAM Health Care Campus, Haifa, Israel
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
- Conditions
- Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 39
- Registration Number
- NCT04540588
- Locations
- 🇮🇱
Sharett institute, Hadassah University Hospital - Ein-Kerem, Jerusalem, Israel
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
- Conditions
- Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 56
- Registration Number
- NCT04534127
- Locations
- 🇮🇱
Sharett institute, Hadassah Medical Center - Ein-Kerem, Jerusalem, Israel
Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors
- Conditions
- Soft Tissue Tumor, MalignantMalignant Skin Tumor
- Interventions
- Radiation: Diffusing Alpha-emitter Radiation Therapy
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2022-06-01
- Lead Sponsor
- Alpha Tau Medical LTD.
- Target Recruit Count
- 10
- Registration Number
- NCT04377360
- Locations
- 🇺🇸
UnityPoint Health - John Stoddard Cancer Center, Des Moines, Iowa, United States
🇺🇸Dermatology of Seattle and Bellevue, Seattle, Washington, United States
🇺🇸University Cancer & Diagnostic Center, Houston, Texas, United States